Vibralactone L is primarily studied for its potential biological activity, particularly as a lipase inhibitor. This property makes it of interest in research related to obesity management, where inhibition of fat digestion and absorption in the gastrointestinal tract is a therapeutic goal. It has been isolated from fungal sources, especially from cultures of Boreostereum vibrans, and shows structural similarity to other bioactive lactones with enzyme inhibitory effects.

Due to its ability to modulate metabolic enzymes, Vibralactone L serves as a lead compound in the development of new agents for controlling lipid metabolism. It is also used in biochemical studies to understand enzyme inhibition mechanisms, especially against pancreatic lipase. While not currently used in clinical medicine, its natural origin and specific activity support ongoing exploration in pharmaceutical and biotechnological applications, including potential use in functional foods or nutraceuticals aimed at weight management.